---
title: "Bambusa Therapeutics climbs 3% as oversubscribed IPO debuts"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303979303.md"
description: "Bambusa Therapeutics rose 3.14% to $15.46 after completing an oversubscribed IPO at $16 that raised $169 million."
datetime: "2026-11-02T15:12:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303979303.md)
  - [en](https://longbridge.com/en/news/303979303.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303979303.md)
generator: "portal-rs"
---

# Bambusa Therapeutics climbs 3% as oversubscribed IPO debuts

Bambusa Therapeutics (BBTX.US) climbed more than **3%** during regular trading to **$15.46**.

The company completed an oversubscribed initial public offering on Oct. 30 at **$16** per share, raising **$169 million**.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [BBTX.US](https://longbridge.com/en/quote/BBTX.US.md)

## Related News & Research

- [Bambusa Therapeutics Director Helmut Wolfgang Jeggle Reports $6 Million Common Share Acquisition](https://longbridge.com/en/news/304008064.md)
- [Peter Kolchinsky and Rajeev Shah Disclose 14.6% Stake in Bambusa Therapeutics](https://longbridge.com/en/news/304691682.md)
- [BUZZ-Street View: Nvidia's AI story intact despite uncertainty at top](https://longbridge.com/en/news/305945171.md)
- [INSTANT VIEW-Nvidia earnings beat estimates; attention turns to call](https://longbridge.com/en/news/305875718.md)
- [Will Upper Stage Recovery Change SpaceX's (SPCX) Narrative](https://longbridge.com/en/news/305914563.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**